Obstructive sleep apnea contribution to oxidative stress in obesity;Contribuição da apnéia obstrutiva do sono para o estresse oxidativo da obesidade

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 4, 2008, Pages 668-676

  De Lima, Anna Myrna Jaguaribe ^a,b   Ribeiro Franco, Clélia M ^a   Barbosa De Castro, Célia M M ^a   Bezerra, Alice De Andrade ^a   Ataíde Jr , Luiz ^a   Halpern, Alfredo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Obesity; Obstructive sleep apnea; Oxidative stress

Indexed keywords

NITRATE; NITRITE; SUPEROXIDE;

ARTICLE; BLOOD; BODY MASS; HUMAN; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME;

BODY MASS INDEX; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; MALE; MIDDLE AGED; NITRATES; NITRITES; OBESITY; OXIDATIVE STRESS; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; SUPEROXIDES;

EID: 47249114087     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302008000400013     Document Type: Article

References (35)

1. Olson EJ, Moore WR, Morgenthaler TI, Gay PC, Staats BA. Obstructive sleep apnea-hypopnea syndrome. Mayo Clin Proc. 2003;78:1545-52.
2. Hamilton GS, Solin P, Naughton MT. Obstructive sleep apnoea and cardiovascular disease. Intern Med J. 2004;34:420-26.
3. Redline S, Kapur VK, Sanders MH, Quan SF, Gottlieb DJ, Rapoport DM, et al. Effects of varying approaches for identifying respiratory disturbances on sleep apnea assessment. Am J Respir Crit Care Med. 2000;161:369-74.
4. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med. 2005;142:187-97.
5. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667-89.
6. Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217-39.
7. Bixler EO, Vgontzas AN, Lin H, Ten Have T, Rein J, Vela-Bueno A, et al. Prevalence of sleep-disordered breathing in women. Am J Respir Crit Care Med. 2002;163:608-13.
8. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med. 1998;157:144-8.
9. Shimura R, Tatsumi K, Nakamura A, Kasahara Y, Tanabe N, Takiguchi Y, et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127:543-9.
10. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ. 1997;314:851-60.
11. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep CPAP in sleep apnoea: a randomised prospective parallel trial. Lancet. 1999;353:2100-5.
12. Hsu AAL, Lo C. Continuous positive airway pressure therapy in sleep apnoea. Respirology. 2003;8:447-54.
13. Yee B, Liu P, Phillips C, Grunstein R. Neuroendocrine changes in sleep apnea. Curr Opin Pulm Med. 2004;10:475-81.
14. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000:162:2166-71.
15. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000;162:566-70.
16. Harsch IA, Koebnick C, Wallaschofski H, Ficker, JH, Lohmann T, Konturek PC. Resistin levels in patients with obstructive sleep apnoea syndrome - the link to subclinical inflammation? Med Sci Monit. 2004;10:CR510-15.
17. Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J. 2003;22:251-7.
18. Narkiewicz K, Somers SK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand. 2003;177:385-90.
19. McCord JM. Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med. 1985;312:159-63.
20. McCord JM. The evolution of free radicals and oxidative Stress. Am J Med. 2000;108:652-9.
21. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, et al. Oxidative stress in obstructive sleep apnea. Chest. 2005;127:1674-9.
22. Suzuki YJ, Jain V, Park AM, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med. 2006;40:1683-92.
23. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotective enzymes in humans. Int J Obes Relat Metab Disord. 2002;26:1159-64.
24. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, et al. Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23:434-9.
25. Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest. 1996;56:577-81.
26. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000;162:566-70.
27. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162:2166-71.
28. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative Stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752-61.
29. Imadojemu VA, Gleeson K, Quraishi SA, Kunselman AR, Sinoway LI, Leuenberger U. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2002;165:950-3.
30. Khalid MA, Ashraf M. Direct detection of endogenous hydroxyl radical production in cultured adult cardiomyocyte during anoxia and reoxygenation: is the hydroxyl radical really the most damaging radical species? Circ Res. 1993;72:725-36.
31. Vargas F, Moreno JM, Wangensteen R, Rodriguez-Gomez I, Garcia-Estan J. The endocrine system in chronic nitric oxide deficiency. Eur J Endocrinol. 2007 Jan;156:1-12.
32. Glebocka A, Kossowska A, Bednarek M. Obstructive sleep apnea and the quality of life. J Physiol Pharmacol. 2006 Sep;57 Suppl 4:111-7.
33. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative Stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is a reduced by continuous positive airway pressure therapy. Chest. 2003;124:1386-92.
34. Weiss JW, Liu MD, Huang J. Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension. Exp Physiol. 2007;92:21-6.
35. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000; 21:2607-10.